PlainRecalls
FDA Drug Moderate Class II Terminated

Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202

Reported: April 25, 2018 Initiated: March 27, 2018 #D-0684-2018

Product Description

Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202

Reason for Recall

Superpotent Drug

Details

Units Affected
40,824 bottles
Distribution
Nationwide
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs ( 68180-723-10), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 40,824 bottles.
Why was this product recalled?
Superpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on April 25, 2018. Severity: Moderate. Recall number: D-0684-2018.